ACADEMIC FRONTIERS
学术前沿
Tolerability and efficacy of pegylated consensus interferonα in the treatment of chronic hepatitis C
上一篇：Association of immune response parameters with virological response in hepatitis C virus patients treated with pegylated consensus interferon
下一篇：Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects.
返回列表
